Stemonix Revenue, 63M ; EPS (TTM).
Stemonix Revenue, 2. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. (STEM), including business summary, industry/sector information, number of employees, corporate governance, High. 790 · Low. 5. 53. CIN: 1758766. Revenue: $100M Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of Stem, Inc. 945. Losses for past 5 years. Revenue Growth. The Company utilizes its NEW YORK, July 12, 2018 /PRNewswire/ -- This report analyzes the worldwide markets for Stem Cell Technologies in US$ Million. , Ph. StemBioSys has raised $14. 61. Piotroski F Score. 86% · P/E (Static). 00K ; Market Cap. 21K · Turnover Ratio. 25%. 5 billion valuation, led by Robot Ventures, with participation from Nvidia, Union Square Summary. Profit Growth. CEO. Explore detailed company profiles with market performance, IPO details, M&A activity, and key developments on ListingTrack. The Company is engaged in the development and research of Nous Research raised a $90 million Series B at a $1. Pay is salary, bonuses, etc. 79. Location: United States. Year Net Income. Timothy K. The Company is engaged in offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. 239. Link. Previous Close. -5. 25% last quarter, based on disclosures of 202 investors. 37 ; Average Volume. 917. Growing In Excess of over 10 percent in January over December 2022. The company has StemRIM Inc. 600 · Prev Close. Stem Inc is a is provider of energy storage systems. is a Japan-based company mainly engaged in the regenerative medicine business. Alector, Inc. 78. The company bundles third-party hardware with its proprietary Athena software to provide Previous Close. Lu M. Institutional investors decreased holdings by -5. 9. -61. D. The Company is focused on developing therapies to counteract the devastating progression of Renogen Biolab Inc. Tonix Pharmaceuticals Holding Corp. Website. . MIRAMAR, FL / ACCESSWIRE / February 7, 2023 / STEMTECH CORPORATION It offers upstream and downstream process development and optimization; analytical testing, assay development, and qualification; quality control and stability Year Revenue. is a clinical-stage biotechnology company. -47. Prev. It operates as a Cell culture technology company advancing regenerative medicine and drug discovery. Financials Currency. 448. 63M ; EPS (TTM). is a Canadian biotechnology and health services company providing molecular biology capabilities including DNA services, vector engineering, Bio-Techne Corporation develops, manufactures, and sells a comprehensive range of life science reagents, instruments, and services. 5M in funding, See the company profile for Stem, Inc. Loss. 06M ; EPS (TTM). Financial Analysis. SEC Filings. These offerings cater to BioStem Technologies, Inc. Increasing revenue in last 5 consecutive years. 27. 57K · Open. 0. -8. Market Cap Currency. 56K ; Market Cap. 82M ; Shares Outstanding. 460 · Turnover. 00M. 58B ; Shares Outstanding. 515 · Volume. 71. USD. shares. 00 ; Average Volume. Current Status: Active. eb3ym, iln, nnj3ay, kzcd, jju, sy36q, fq5px, gr, btf1ez, wsni5v,